Details for: LOTEMAX GEL
Company: BAUSCH & LOMB INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02435853 | LOTEMAX GEL | LOTEPREDNOL ETABONATE | 0.5 % / W/W | GEL | OPHTHALMIC |
Consumer Information
This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.
What the medication is used for
Lotemax® Gel is used for the treatment of post-operative inflammation and pain following cataract surgery.
What it does
Lotemax® Gel is a corticosteroid and is believed to act by reducing the production of substances associated with inflammation, including prostaglandins and leukotrienes. By reducing these substances inflammation and pain are reduced..
When it should not be used
Do not use Lotemax® Gel:
- If you are allergic to loteprednol or any of the ingredients contained in Lotemax® Gel (see What the important nonmedicinal ingredients are) or if you are allergic to any other corticosteroid.
- If you have eye infections caused by viruses such as herpes simplex, vaccinia and varicella or caused by bacteria or a fungus or if you think you have any other eye infection
What the medicinal ingredient is
The medicinal ingredient is loteprednol etabonate. Each mL contains 5 mg (0.5% w/w) loteprednol etabonate.
What the non-medicinal ingredients are
Boric acid, edetate disodium dihydrate, glycerin, polycarbophil, propylene glycol, sodium chloride, tyloxapol, water for injection, and sodium hydroxide. The preservative is benzalkonium chloride 0.003% w/w.
What dosage form it comes in
Sterile ophthalmic gel 0.5% w/w.
Warnings and precautions
BEFORE you use Lotemax® Gel talk to your doctor or pharmacist:
- you have an eye disease/infection caused by viruses such as herpes simplex, vaccinia and varicella or caused by bacteria or a fungus or if you think you have any other eye infection.
- If you had or have glaucoma or increased pressure in the eye as Lotemax® Gel might increase the pressure in the eye. Glaucoma, which occurs when the pressure in the eye increases for a period of time, can cause damage to the optic nerve, vision problems, and sometimes a loss of vision. Your doctor may monitor your intraocular pressure.
- If signs and symptoms fail to improve after two days of using Lotemax® Gel, consult your doctor
- If you are pregnant or planning to become pregnant. Lotemax® Gel should not be used in pregnant women unless the doctor determines this is appropriate for you as there might be a risk of harm to the embryo or fetus.
- If you are breastfeeding or planning to breastfeed. Lotemax® Gel should not be used in breastfeeding women unless the doctor determines that this is appropriate for the infant as there might be a risk of harm to the nursing baby.
- If you are under 18 years of age.
Consult your doctor if the following occurs while taking Lotemax® Gel:
- If you develop an eye infection or other new or worsening symptoms.
- If you develop a blister on the eye (a bleb).
Interactions with this medication
Drug interaction studies have not been done for Lotemax® Gel.
Please inform your doctor or pharmacist if you are taking or have taken recently any other medicines, even those not prescribed.
Proper use of this medication
Usual dose
For adults only.
Invert closed bottle and shake once to fill tip before instilling
drops.
Apply one or two drops of Lotemax® Gel into the conjunctival sac
(see pictogram) of the affected eye four times daily beginning the
day after surgery and continuing throughout the first 2 weeks of
the postoperative period.
- Do not allow the dropper tip to touch any surface as this may contaminate the gel. The cap should remain on the bottle when not in use
- Use only if imprinted neckband is intact
- Wash hands prior to using Lotemax® Gel
- Do not wear contact lenses during the course of therapy
- Do not use if tamper evident skirt is visible on bottom of cap
- If pain develops, redness, itching or inflammation becomes aggravated, consult your doctor.
- If you are using another medication in the eye, wait at least 15 minutes before applying.
Overdose
Missed Dose
If you miss a dose, take the next dose as scheduled then continue as before. Do not double doses
Side effects and what to do about them
Eye gel can cause your vision to be blurred. This usually passes quickly. Do not drive or use machines until your vision is clear. Like all medicines, Lotemax® Gel can have unwanted effects. The most common side effects in patients treated with Lotemax® Gel are:
- Increased pressure within the eye
- Blurred or abnormal vision
- Swelling or discharge from the eyes
- Painful, dry or sticky eyes
- Tearing
- Sensation of having an object in your eye
- Itching in the eye or on the eyelid
- Redness in the eye or on the eyelid
- Photophobia (discomfort on exposure to light)
Another unwanted effect might include headache, nausea, cold, sore throat, runny nose, dizziness or rash.
If you notice these or any other effects, tell your doctor or pharmacist.
This is not a complete list of side effects. For any unexpected effects while taking Lotemax® Gel, contact your doctor or pharmacist.
How to store
Store upright between 15 - 25ºC (59-77ºF) for up to 28 days after first opening.
Keep out of reach and sight of children.
Reporting side effects
You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:
- Report online at www.healthcanada.gc.ca/medeffect
- Call toll-free at 1-866-234-2345
- Complete a Canada Vigilance Reporting Form and:
- Fax toll-free to 1-866-678-6789, or
- Mail to: Canada Vigilance Program
Health Canada
Postal Locator 0701D
Ottawa, Ontario
K1A 0K9
Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.
NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.
More information
This document plus the full product monograph, prepared for
health professionals can be found at:
http://www.bausch.ca
or by contacting the sponsor, Bausch & Lomb Incorporated, at:
1-888-459-5000
This leaflet was prepared by Bausch & Lomb Incorporated
Last revised: December 22, 2014.